Surely, even you don't think Blinatumomab will be doing the heavy lifting in killing these "target less" cancer cell otherwise they would be doing clinical trial to capture this massive cancer market.
Honestly.
- Forums
- ASX - By Stock
- Ann: First Australian Patient Dosed in Phase 1b azer-cel Trial
IMU
imugene limited
Add to My Watchlist
4.17%
!
1.2¢

Surely, even you don't think Blinatumomab will be doing the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.2¢ |
Change
-0.001(4.17%) |
Mkt cap ! $82.13M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.1¢ | $177.0K | 14.73M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
76 | 16858624 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 16837721 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
75 | 16767715 | 0.011 |
80 | 23229175 | 0.010 |
24 | 7564263 | 0.009 |
9 | 1739999 | 0.008 |
5 | 1780000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 16837721 | 31 |
0.013 | 13080503 | 32 |
0.014 | 8359185 | 33 |
0.015 | 9008204 | 32 |
0.016 | 7428011 | 30 |
Last trade - 14.42pm 25/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |